MX9302832A - Nuevo medicamento para el tratamiento de la arritmia. - Google Patents

Nuevo medicamento para el tratamiento de la arritmia.

Info

Publication number
MX9302832A
MX9302832A MX9302832A MX9302832A MX9302832A MX 9302832 A MX9302832 A MX 9302832A MX 9302832 A MX9302832 A MX 9302832A MX 9302832 A MX9302832 A MX 9302832A MX 9302832 A MX9302832 A MX 9302832A
Authority
MX
Mexico
Prior art keywords
arrhythmia
treatment
new medicine
alkylene
pharmaceutically acceptable
Prior art date
Application number
MX9302832A
Other languages
English (en)
Inventor
Bernard Emile Joseph Gout
Antoine Michel Alain Bril
Jean-Francois Simon Pier Favre
Marie-Claire Forest
Original Assignee
Smithkline Beecham Lab
Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Lab, Pharma filed Critical Smithkline Beecham Lab
Publication of MX9302832A publication Critical patent/MX9302832A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

Se describe un método para el tratamiento de la arritmia en mamíferos humanos y no humanos, método el cual comprende la administración de una cantidad efectiva, no tóxica de un compuesto de fórmula (I): R1, N(R2) AN(R3)BR4, o una sal farmacéuticamente aceptable del mismo y/o un solvato farmacéuticamente aceptable del mismo, en el que A representa alquileno de C2-5; y B representa alquileno de C1-4; los compuestos y composiciones farmacéuticas para uso en tal método.-
MX9302832A 1992-05-14 1993-05-14 Nuevo medicamento para el tratamiento de la arritmia. MX9302832A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9205855A FR2691064B3 (fr) 1992-05-14 1992-05-14 Nouveau medicament pour le traitement de l'arythmie.

Publications (1)

Publication Number Publication Date
MX9302832A true MX9302832A (es) 1994-07-29

Family

ID=9429783

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302832A MX9302832A (es) 1992-05-14 1993-05-14 Nuevo medicamento para el tratamiento de la arritmia.

Country Status (14)

Country Link
EP (2) EP0639973A1 (es)
JP (2) JP2779269B2 (es)
KR (1) KR950701517A (es)
AP (1) AP410A (es)
AU (2) AU677190B2 (es)
CA (1) CA2135612A1 (es)
FR (1) FR2691064B3 (es)
HU (1) HUT72634A (es)
IL (1) IL105690A0 (es)
MX (1) MX9302832A (es)
SG (1) SG47098A1 (es)
TW (1) TW366283B (es)
WO (1) WO1993023024A1 (es)
ZA (1) ZA933376B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2691064B3 (fr) * 1992-05-14 1996-01-12 Beecham Laboratoires Nouveau medicament pour le traitement de l'arythmie.
FR2694557B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
FR2710065B1 (fr) * 1993-09-13 1996-10-04 Smithkline Beecham Labo Pharma Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
AU1949795A (en) * 1995-03-08 1996-09-23 Smithkline Beecham Laboratoires Pharmaceutiques Heterocyclycarboxamides and other compounds for the treatment of the cardiac arrhythmias

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242344A1 (de) * 1982-11-16 1984-05-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue alkylendiaminoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4751327A (en) * 1985-06-28 1988-06-14 Xerox Corporation Photoconductive imaging members with unsymmetrical squaraine compounds
GB8603765D0 (en) * 1986-02-15 1986-03-19 Beecham Wuelfung Gmbh & Co Kg Compounds
EP0484378B1 (en) * 1989-07-25 1994-09-14 The Upjohn Company Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides
US5051422A (en) * 1989-09-15 1991-09-24 Schering Ag 2-substituted-1(4)-aryl piperazines and the process for their preparation
FR2691064B3 (fr) * 1992-05-14 1996-01-12 Beecham Laboratoires Nouveau medicament pour le traitement de l'arythmie.

Also Published As

Publication number Publication date
FR2691064B3 (fr) 1996-01-12
EP0852142A1 (en) 1998-07-08
AU4067093A (en) 1993-12-13
KR950701517A (ko) 1995-04-28
JPH07506824A (ja) 1995-07-27
HUT72634A (en) 1996-05-28
CA2135612A1 (en) 1993-11-25
JPH09118635A (ja) 1997-05-06
AP410A (en) 1995-09-28
EP0639973A1 (en) 1995-03-01
FR2691064A1 (fr) 1993-11-19
ZA933376B (en) 1995-02-14
WO1993023024A1 (en) 1993-11-25
IL105690A0 (en) 1993-09-22
AU1485197A (en) 1997-05-15
AP9300527A0 (en) 1993-07-31
AU677190B2 (en) 1997-04-17
JP2779269B2 (ja) 1998-07-23
TW366283B (en) 1999-08-11
SG47098A1 (en) 1998-03-20

Similar Documents

Publication Publication Date Title
SE8300736D0 (sv) Novel pharmacologically active compounds
LU90192I2 (fr) Desirudine et ses sels et dérivés pharmaceutiquement acceptables (revasc)
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
MX9203239A (es) Derivados de 1-(dihidroxifenil)-2-amino-etanol y composiciones farmaceuticas que los contienen.
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
AR019053A1 (es) Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen
MX9305947A (es) Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
FI913034A0 (fi) Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning.
MX9302832A (es) Nuevo medicamento para el tratamiento de la arritmia.
IT8867891A0 (it) Derivati terziobutilati di benzilidene canfora procedimento per la loro preparazione,loro impiego come agenti anti ossidanti e composizioni cosmetiche e farmaceutiche che li contengono
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
ES2072386T3 (es) Derivados del penciclovir para el tratamiento de las infecciones de hepatitis-b.
SE8802066D0 (sv) N-imidazolyl derivatives of bicyclic compounds useful in medicine
MX9203068A (es) Compuestos activirales oralmente activos.
ES2171749T3 (es) Composiciones farmaceuticas que contienen inhibidores de la agregacion de plaquetas.
DE3160851D1 (en) Lidocaine derivative and therapeutic compositions which contain it as their active principle
AR031846A1 (es) Combinacion de sustancias activas, medicamentos y formulaciones que la contienen, y uso de la misma para la preparacion de un medicamento para el tratamiento del dolor